Bavarian Nordic A/S
7.4.2026 10:47:11 CEST | Globenewswire | Press release
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
COPENHAGEN, Denmark, April 7, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on March 12, 2026, under which the Company will repurchase shares for an amount up to DKK 200 million in the period from March 12, 2026 to May 13, 2026. The program is executed in accordance with Regulation (EU) No. 596/2014 (as amended) of the European Parliament and of the Council on market abuse and Commission Delegated Regulation (EU) 2016/1052, which together constitute the Safe Harbour Regulation.
Since the last announcement of transactions on March 30, 2026, the following transactions have been made by Nordea on behalf of Bavarian Nordic:
| Number of shares | Average purchase price, DKK | Transaction value, DKK | |
| Accumulated until March 30, 2026 | 331,913 | 185.16 | 61,457,511 |
| March 30, 2026 | 50,000 | 191.46 | 9,572,990 |
| March 31, 2026 | 13,000 | 192.98 | 2,508,758 |
| April 1, 2026 | 4,722 | 196.17 | 926,327 |
| Accumulated under the program | 399,635 | 186.33 | 74,465,587 |
The details for each transaction made under the share repurchase program are published on bavarian-nordic.com.
Following these transactions, Bavarian Nordic holds a total of 2,097,396 treasury shares, corresponding to 2.65% of the Company’s share capital.
About Bavarian Nordic
Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. For more information, visit www.bavarian-nordic.com
Forward-looking statements
This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of our control, that could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning our plans, objectives, goals, future events, performance and/or other information that is not historical information. All such forward-looking statements are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances after the date made, except as required by law.
Contact investors:
Europe: Disa Tuominen, IR Manager, detu@bavarian-nordic.com
US: Graham Morrell, Gilmartin Group, graham@gilmartinir.com, Tel: +1 781 686 9600
Contact media:
Nicole Seroff, Vice President Corporate Communications, nise@bavarian-nordic.com, Tel: +45 53 88 06 03
Company Announcement no. 16 / 2026
Attachments
- Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
- Appendix with detailed transaction data
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Nordea Bank Abp.7.4.2026 12:09:39 CEST | Press release
Delisting of Exchange Traded Products
Strategic Investments A/S7.4.2026 12:08:08 CEST | Pressemeddelelse
Meddelelse nr. 09/2026: Indkaldelse til ordinær generalforsamling
HMS Networks AB7.4.2026 12:03:04 CEST | Press release
Invitation to HMS Networks’ first quarter conference call 2026
AscellaHealth, LLC7.4.2026 12:00:00 CEST | Press release
AscellaHealth Named to Financial Times Americas’ Fastest Growing Companies 2026 List
Lassila & Tikanoja Plc7.4.2026 11:00:00 CEST | Press release
Lassila & Tikanoja’s Annual Report 2025 has been published
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom